Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 42,294,000 | 40,122,000 | 39,807,000 | 39,498,000 | 42,237,000 |
| Cost of Goods | 13,509,000 | 12,912,000 | 14,030,000 | 14,934,000 | 16,768,000 |
| Gross Profit | 28,785,000 | 27,210,000 | 25,777,000 | 24,564,000 | 25,469,000 |
| Operating Expenses | 19,854,000 | 20,413,000 | 20,278,000 | 17,017,000 | 18,786,000 |
| Operating Income | 8,931,000 | 6,797,000 | 5,499,000 | 7,547,000 | 6,683,000 |
| Other Income | -230,000 | -276,000 | -840,000 | -2,146,000 | 10,600,000 |
| Pre-tax Income | 8,701,000 | 6,521,000 | 4,659,000 | 5,401,000 | 17,283,000 |
| Income Tax | 2,508,000 | 4,103,000 | 718,000 | 942,000 | 5,349,000 |
| Net Income Continuous | 6,193,000 | 2,418,000 | 3,941,000 | 4,459,000 | 11,934,000 |
| Minority Interests | -27,000 | 24,000 | 21,000 | 17,000 | 14,000 |
| Net Income | $6,220,000 | $2,394,000 | $3,920,000 | $4,442,000 | $11,920,000 |
| EPS Basic Total Ops | 2.34 | 0.88 | 1.42 | 1.58 | 4.12 |
| EPS Basic Continuous Ops | 2.32 | 0.89 | 1.42 | 1.58 | 4.12 |
| EPS Diluted Total Ops | 2.32 | 0.87 | 1.41 | 1.56 | 4.07 |
| EPS Diluted Continuous Ops | 2.31 | 0.88 | 1.41 | 1.57 | 4.08 |
| EPS Diluted Before Non-Recurring Items | 4.34 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $13,450,000 | $11,473,000 | $10,970,000 | $13,922,000 | $13,374,000 |